Brown & Brown, Inc (BRO) concluded trading on Wednesday at a closing price of $104.48, with 21.3 million shares of worth about $2.23 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.30% during that period and on June 11, 2025 the price saw a loss of about -0.96%. Currently the company’s common shares owned by public are about 287.00M shares, out of which, 237.39M shares are available for trading.
Stock saw a price change of -6.03% in past 5 days and over the past one month there was a price change of -5.67%. Year-to-date (YTD), BRO shares are showing a performance of 2.41% which increased to 15.73% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $88.31 but also hit the highest price of $125.68 during that period. The average intraday trading volume for Brown & Brown, Inc shares is 1.81 million. The stock is currently trading -5.47% below its 20-day simple moving average (SMA20), while that difference is down -7.73% for SMA50 and it goes to -4.51% lower than SMA200.
Brown & Brown, Inc (NYSE: BRO) currently have 287.00M outstanding shares and institutions hold larger chunk of about 77.71% of that.
The stock has a current market capitalization of $29.95B and its 3Y-monthly beta is at 0.83. PE ratio of stock for trailing 12 months is 29.13, while it has posted earnings per share of $3.59 in the same period. Its PEG reads 3.05 and has Quick Ratio of 1.20 while making debt-to-equity ratio of 0.59. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BRO, volatility over the week remained 1.36% while standing at 1.20% over the month.
Stock’s fiscal year EPS is expected to rise by 8.57% while it is estimated to increase by 9.99% in next year. EPS is likely to shrink at an annualized rate of 9.54% for next 5-years, compared to annual growth of 19.72% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on May 13, 2025 offering a Neutral rating for the stock and assigned a target price of $119 to it. On March 25, 2025, Morgan Stanley Downgrade their recommendations, while on December 05, 2024, Morgan Stanley Initiated their ratings for the stock with a price target of $134. Stock get a Buy rating from Argus on September 24, 2024.
